21 results
424B3
BBLNF
Babylon Holdings Ltd
17 Jun 22
Prospectus supplement
5:01pm
oversee and manage ESG issues and evaluate our ESG objectives by using industry-specific frameworks such as the Sustainability Accounting Standards … sustainability through the reuse and remanufacture of medical devices. The regime is expected to come into force in July 2023, coinciding with the end
F-4
BBLNF
Babylon Holdings Ltd
20 May 22
Registration of securities (foreign)
5:13pm
and manage ESG issues and evaluate our ESG objectives by using industry-specific frameworks such as the Sustainability Accounting Standards Board … intelligence as medical devices, reform in vitro diagnostic medical devices regulation, and foster sustainability through the reuse and remanufacture
6-K
EX-99.1
BBLNF
Babylon Holdings Ltd
12 May 22
Babylon Delivers Massive Growth and Adjusted EBITDA Margin Improvement in the First Quarter of 2022 and Raises 2022 Revenue Guidance
6:00am
increased debt funding for $100 million through a sustainability-linked investment from AlbaCore Capital Group which is focused on ESG investing. We
424B3
BBLNF
Babylon Holdings Ltd
9 May 22
Prospectus supplement
4:15pm
such as the Sustainability Accounting Standards Board standards (promulgated by the Value Reporting Foundation) and elements of the United Nations Sustainable … regulation, and foster sustainability through the reuse and remanufacture of medical devices. The regime is expected to come into force in July 2023
424B3
BBLNF
Babylon Holdings Ltd
3 May 22
Prospectus supplement
4:16pm
by using industry-specific frameworks such as the Sustainability Accounting Standards Board standards (promulgated by the Value Reporting Foundation … as medical devices, reform in vitro diagnostic medical devices regulation, and foster sustainability through the reuse and remanufacture of medical
F-1
fiou3so
29 Apr 22
Registration statement (foreign)
5:09pm
POS AM
gxtufjc
28 Apr 22
Prospectus update (post-effective amendment)
5:28pm
424B3
ldbex4 onv
30 Mar 22
Prospectus supplement
5:19pm
20-F
cxwuf vs6
30 Mar 22
Annual report (foreign)
4:12pm
6-K
EX-99.1
fr1phenv
10 Mar 22
Babylon Delivers Four-Fold Revenue Growth in 2021 and On Track to Meet Three-Fold 2022 Revenue Growth to up to $1 Billion
6:08am
424B4
bpqbu
30 Nov 21
Prospectus supplement with pricing info
5:27pm
6-K
EX-99.1
lyenaw
12 Nov 21
Babylon Delivers Strong Third Quarter 2021 Operational and Financial Results
6:14am
F-1
iqgn uegh24w
9 Nov 21
Registration statement (foreign)
12:00am
6-K
EX-99.1
wb8bb2
21 Oct 21
Babylon, one of the world’s fastest-growing digital healthcare companies, to begin trading on the New York Stock Exchange under the ticker BBLN
5:03pm
425
k2ag6gv5
8 Oct 21
Business combination disclosure
4:39pm
424B3
viawymantbdu9 0a4fw
30 Sep 21
Prospectus supplement
4:54pm
F-4/A
0tlo9nn he6m32ka1v
27 Sep 21
Registration of securities (foreign) (amended)
10:48am
F-4/A
ku0mn0i s7284qbms
15 Sep 21
Registration of securities (foreign) (amended)
8:34am
F-4/A
239lw7phpz3w5 4squ
24 Aug 21
Registration of securities (foreign) (amended)
4:08pm
F-4/A
3pye rexu
9 Aug 21
Registration of securities (foreign) (amended)
12:00am